Stand out for this role — generate a tailored resume and cover letter in about a minute.
Pierre Fabre Pharmaceuticals Inc. is seeking a US Vice President of Value and Access to lead and evolve a high-impact team focused on securing patient access and optimizing pricing, coverage, and reimbursement for our oncology and rare-disease portfolio.
The role emphasizes collaboration with Medical Affairs, Regulatory, and Global Value & Access to support Cell therapy launches and future therapies. The candidate will shape payer value propositions, HEOR strategies, and distribution policies
At Pierre Fabre Pharmaceuticals Inc. our mission is to deliver breakthrough therapies in oncology and rare diseases to patient populations with high unmet needs and limited treatment options. Our belief is that every time we care for a single person, we make the whole world better. We are the US pharmaceutical subsidiary of Pierre Fabre Laboratories Worldwide, a foundation-owned company with 7 decades of impact. Pierre Fabre Laboratories is a truly global healthcare company, established in 43 countries, with products distributed in 119 territories across the globe. Pierre Fabre's foundation ownership enhances our ability to focus on creating long-term value for patients.
Building on the legacy of Pierre Fabre Laboratories, innovation is our life blood and patient experience drives everything we do. We aspire to design and develop therapeutic solutions inspired by patients and healthcare professionals; draw on science and nature as perpetual sources of inspiration; develop long-term partnerships with researchers and innovators worldwide; and place pharmaceutical ethics and climate transition at the heart of our action.
Pierre Fabre Pharmaceuticals is headquartered in Secaucus, NJ alongside Pierre Fabre USA Inc., a Pierre Fabre Laboratories subsidiary focused on dermatology and cosmetics.
The US Vice President - Value and Access is a key member of Pierre Fabre Pharmaceuticals Inc. leadership team. Reporting directly to theChief Commercial Officer, the incumbent is responsible for securing and enabling patient access to our portfolio of products across all payer and relevant distribution channels, while maximizing value to PFP. Incumbent will develop and support the execution of strategies for securing pricing, coverage, and reimbursement for company portfolio. The VP of Value and Access’ primary priority is to support the successful launch and commercialization of cell therapy (tabelecleucel) and future rare disease therapies from the value and access standpoint. The VP of Value and access will be focused on delivering access to innovative solutions for complex patients suffering from a devastating rare disease, Epstein-Barr Virus Positive Post Transplant Lymphoproliferative Disease (EBV+ PTLD). Patients with a history of bone marrow or solid organ transplant can suffer from this rare, often deadly lymphoma, which currently has no approved FDA therapies.
Activities conducted by the Vice President – Value and Access will include but are not limited to direct leadership of dynamic team of V&A Access professionals, development of payer value proposition, reimbursement strategy, HEOR strategy, distribution and trade policy. Incumbent will be accountable for establishing metrics to monitor patient access and for refining strategies and programs accordingly to optimize access and enable commercial success.
Given the complexities of cell therapy, this role will play a critical part in addressing site of care dynamics, centers of excellence networks, single case agreements, and distribution network expansion to enable broad access across both academic and community centers. This role requires a thorough understanding of the complexities of the US Healthcare system as related to advanced therapies, orphan drugs and across sites of care (inpatient/ outpatient).
This leader will work in close collaboration with multiple internal partners such as Patient Affairs, Medical Affairs, Regulatory Affairs, Global Value & Access organization, marketing, Technical Operations, Clinical Development, Global Value & Access and external stakeholders.
US, remote and/or hybrid
Anticipated Salary Range: $320,000 - $390,000
This range represents the base annual full-time salary for all positions within the applicable job grade. The actual salary offer will depend on a range of factors including experience, education, location, and other relevant qualifications. This position is also eligible for a Pierre Fabre bonus, commission, or incentive program in addition to the base pay.
Employees will be eligible to participate in a comprehensive benefits package that includes medical, dental, and vision coverage, voluntary benefits, a 401(k) retirement plan, a generous PTO policy, paid company holidays, and paid parental leave. Additional offerings include employee discounts on our products, professional development opportunities, and access to mental health and wellness programs
Pierre Fabre has been recognized by Forbes as one of the "World's Best Employers" for the 3rd year running.
Pierre Fabre is an equal employment opportunity employer and does not discriminate against any applicant because of race, creed, color, age, national origin, ancestry, religion, gender, sexual orientation, gender expression and identity, disability, genetic information, veteran status, military status, application for military service or any other class protected by state or federal law.